Table 1.
TBII assays | Biological assays | |
---|---|---|
Advantages | Freely available commercially | Differentiate between stimulating and blocking activities of TRAb |
Relatively cheap | ||
Easy to perform | ||
Sensitive 2nd-3rd generation assays available | ||
| ||
Disadvantages | Do not differentiate between stimulating and blocking activities of TRAb | Most are technically complex and time consuming |
Lack absolute correlation with clinical phenotype | Relatively expensive | |
No correlation with severity of illness | ||
Lack predictive value for GD outcome |
TBII are easy to perform, cheap and are highly sensitive. They remain the preferred assay method of choice in clinical practice. Bioassays have the ability to differentiate between stimulating and blocking TRAb, but the utility of this property in day-to-day clinical practice is unclear. Furthermore, they require greater technical expertise to perform and currently are more expensive.